Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
The Lancet. HIV
|
August 4, 2023
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study
Kristina M Brooks, Jennifer J Kiser, Lauren Ziemba, et al.
The Lancet. HIV
|
March 6, 2025
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Carolyn Bolton Moore, Kristin Baltrusaitis, Brookie M Best, et al.
Science Translational Medicine
|
July 5, 2023
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana
Roger L Shapiro, Gbolahan Ajibola, Kenneth Maswabi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 8, 2022
Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents
Brian T Fisher, Craig L K Boge, Rui Xiao, et al.
Science Translational Medicine
|
May 6, 2026
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines
Alka Khaitan, Jane C Lindsey, Edmund V Capparelli, et al.
Blood Advances
|
May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
Kitsada Wudhikarn, Megan M Herr, Min Chen, et al.
Journal of the Pediatric Infectious Diseases Society
|
November 8, 2024
Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network
Robert F T Bucayu, Craig L K Boge, Inci Yildirim, et al.
Journal of the Pediatric Infectious Diseases Society
|
August 10, 2021
Comparative Effectiveness of Echinocandins vs Triazoles or Amphotericin B Formulations as Initial Directed Therapy for Invasive Candidiasis in Children and Adolescents
Brian T Fisher, Theoklis E Zaoutis, Rui Xiao, et al.
Journal of the Pediatric Infectious Diseases Society
|
August 17, 2023
Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal Network
Rachel L Wattier, Robert F T Bucayu, Craig L K Boge, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
The Lancet. HIV
|
August 4, 2023
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study
Kristina M Brooks, Jennifer J Kiser, Lauren Ziemba, et al.
The Lancet. HIV
|
March 6, 2025
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Carolyn Bolton Moore, Kristin Baltrusaitis, Brookie M Best, et al.
Science Translational Medicine
|
July 5, 2023
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana
Roger L Shapiro, Gbolahan Ajibola, Kenneth Maswabi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 8, 2022
Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents
Brian T Fisher, Craig L K Boge, Rui Xiao, et al.
Science Translational Medicine
|
May 6, 2026
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines
Alka Khaitan, Jane C Lindsey, Edmund V Capparelli, et al.
Blood Advances
|
May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
Kitsada Wudhikarn, Megan M Herr, Min Chen, et al.
Journal of the Pediatric Infectious Diseases Society
|
November 8, 2024
Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network
Robert F T Bucayu, Craig L K Boge, Inci Yildirim, et al.
Journal of the Pediatric Infectious Diseases Society
|
August 10, 2021
Comparative Effectiveness of Echinocandins vs Triazoles or Amphotericin B Formulations as Initial Directed Therapy for Invasive Candidiasis in Children and Adolescents
Brian T Fisher, Theoklis E Zaoutis, Rui Xiao, et al.
Journal of the Pediatric Infectious Diseases Society
|
August 17, 2023
Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal Network
Rachel L Wattier, Robert F T Bucayu, Craig L K Boge, et al.
Page
of 6